Anti-NKG2D antibody [EPR24072-342]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Anti-NKG2D antibody [EPR24072-342] (ab302907) is a rabbit monoclonal antibody detecting NKG2D in IHC-P, mIHC. Suitable for Human.
- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
CD314, D12S2489E, NKG2D, KLRK1, NKG2-D type II integral membrane protein, Killer cell lectin-like receptor subfamily K member 1, NK cell receptor D, NKG2-D-activating NK receptor
- IHC
Supplier Data
Immunohistochemistry - Anti-NKG2D antibody [EPR24072-342] (AB302907)
Immunohistochemical analysis of paraffin-embedded Human NK/T cell lymp tissue labeling NKG2D with ab302907 at 1/2000 (0.258 ug/ml) followed by a LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Positive staining on human NK/T cell lymphoma. The section was incubated with ab302907 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC
Supplier Data
Immunohistochemistry - Anti-NKG2D antibody [EPR24072-342] (AB302907)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling NKG2D with ab302907 at 1/2000 (0.258 ug/ml) followed by a LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Positive staining on human tonsil. The section was incubated with ab302907 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC
Supplier Data
Immunohistochemistry - Anti-NKG2D antibody [EPR24072-342] (AB302907)
Immunohistochemical analysis of paraffin-embedded Human cardiac muscle tissue labeling NKG2D with ab302907 at 1/2000 (0.258 ug/ml) followed by a LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Negative control : no staining on human cardiac muscle. The section was incubated with ab302907 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-NKG2D antibody [EPR24072-342] (AB302907)
Multichannel (Multiplex) immunohistochemistry analysis of Formalin/PFA-fixed paraffin-embedded sections of human tonsil tissue labeling NKG2D, NKG2a, and CD8 alpha. Panel A : merged staining of anti-CD8 alpha (red; Opal™690), anti-NKG2A (gray; Opal™520) and anti-NKG2D (green; Opal™570) on human tonsil. Panel B : anti-NKG2D (ab302907 at 1 : 2000 dilution (0.258 μg/ml)) signal on NK cells and T cell subsets. Panel C : anti-NKG2A (ab260035 at 1 : 2000 dilution (0.283 μg/ml)) signal on NK cells. Panel D : anti-CD8 alpha (ab178089 at 1 : 100 dilution (0.83 μg/ml)) signal on T cell subsets. Opal Polymer HRP Ms + Rb was used as secondary antibody. The section was incubated in three rounds of staining : in the order of ab178089, ab260035, and ab302907 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Nuclear counterstain was DAPI. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
Related conjugates and formulations (2)
-
Anti-NKG2D antibody [EPR24072-342] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-NKG2D antibody [EPR24072-342]
Reactivity data
Product details
What is this antibody validated in?
Anti-NKG2D antibody [EPR24072-342] (ab302907) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Multiplex IHC (mIHC) in Human samples.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR24072-342] also available for your convenience: ab302907, Carrier free - ab302908, Alexa Fluor® 647 - ab312904
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NKG2D acts as an activating receptor on the cell surface that initiates immune responses leading to cytotoxicity against target cells. It functions as part of a complex involving the adaptor protein DAP10 which transduces activating signals to promote cellular immune responses. This interaction amplifies the activation of immune cells and contributes to the host's defense against tumors and virally infected cells.
Pathways
NKG2D plays a significant role in immune surveillance and signaling pathways. It actively involves in the natural killer (NK) cell-mediated cytotoxicity pathway and the adaptive immune response pathway. The interaction with proteins such as DAP10 is critical for its signaling function contributing to its interaction within these pathways. The signaling through NKG2D directly affects the activation states and responses of immune cells which are vital in immune defense.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:294 PubMed39972413
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1250920 PubMed38077388
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com